13F filer · CIK 1065521 ↗
SoftBank Group
You are looking at Q1 2021. See the latest, Q2 2026 →
Reported value
$14.58B
−8.6% on the quarter before
Positions
5
2 new · 1 sold out
Top 10
100.0%
of the value
Est. gain
+$0.00
on stocks held all quarter
Est. return
+0.0%
on those stocks since Q4 2020
Positions as of Mar 31, 2021, from SoftBank Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2020. Striped tiles are options.
Largest buys
Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Afya Ltd~$0.00New · 0.0% → 0.0%−0 shares
- DoorDash~$0.00New · 0.0% → 0.0%−0 shares
Largest sells
Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
Holdings
As of Mar 31, 2021. Changes are in shares against Dec 31, 2020, so a price move alone never reads as a buy or a sale.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $18.17B+59% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $11.41B−26% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $15.47B−40% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $25.97B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $24.94B−15% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $29.31B+25% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $23.37B+6% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $21.95B−44% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 (amended) | $39.11B+105% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $19.06B+3% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $18.54B+6% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $17.56B+97% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.92B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $7.76B+16% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $6.66B−1% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $6.76B−14% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $7.83B−22% | SEC ↗ |
| Q1 2022 | Sep 21, 2022 (amended) | $9.99B−7% | SEC ↗ |
| Q4 2021 | Sep 21, 2022 (amended) | $10.75B−5% | SEC ↗ |
| Q3 2021 | Feb 22, 2022 (amended) | $11.26B−42% | SEC ↗ |
| Q2 2021 | Nov 15, 2021 (amended) | $19.33B+33% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $14.58B−9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $15.95B+23% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $12.92B−26% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $17.52B−41% | SEC ↗ |
| Q1 2020 | Oct 2, 2020 | $29.70B+65% | SEC ↗ |
| Q4 2019 | Oct 2, 2020 | $17.95B−16% | SEC ↗ |
| Q3 2019 | Oct 9, 2020 | $21.26B−6% | SEC ↗ |
| Q2 2019 | Oct 9, 2020 | $22.64B+16% | SEC ↗ |
| Q1 2019 | Oct 9, 2020 | $19.49B−3% | SEC ↗ |
| Q4 2018 | Oct 9, 2020 | $20.15B−11% | SEC ↗ |
| Q3 2018 | Oct 16, 2020 | $22.56B+21% | SEC ↗ |
| Q2 2018 | Oct 16, 2020 | $18.60B+11% | SEC ↗ |
| Q1 2018 | Oct 16, 2020 | $16.68B−16% | SEC ↗ |
| Q4 2017 | Oct 16, 2020 | $19.96B−23% | SEC ↗ |
| Q3 2017 | Oct 23, 2020 | $25.91B−17% | SEC ↗ |
| Q2 2017 | Oct 23, 2020 | $31.25B−2% | SEC ↗ |
| Q1 2017 | Oct 23, 2020 | $31.73B+3% | SEC ↗ |
| Q4 2016 | Oct 23, 2020 | $30.81B+40% | SEC ↗ |
| Q3 2016 | Oct 30, 2020 | $22.02B+45% | SEC ↗ |
| Q2 2016 | Oct 30, 2020 | $15.17B+30% | SEC ↗ |
| Q1 2016 | Oct 30, 2020 | $11.69B | SEC ↗ |